Barrington Research Downgrades Haemonetics (HAE) to Market Perform
Barrington Research downgraded Haemonetics (NYSE: HAE) from Outperform to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
